Towards a more efficient use of registry-based real-world data in Europe: the More-EUROPA project

As the use of real-world data (RWD) to augment clinical trial data in the regulatory and health technology assessment (HTA) decision-making process increases, several initiatives are emerging to ensure the evidence generated is fit-for-purpose and trustworthy. Five projects, part of the MetReal cluster, have received funding from the European Union and over a 4- to 5-year period will seek to explore the usability of RWD. In this interview, we speak with Peter Mol and Sieta de Vries (University Medical Center Groningen) to learn more about the More-EUROPA project and its work towards a more efficient use of RWD in the...